Servier Pharmaceuticals LLC

70 patents currently held · Updated Nov 15, 2026

3 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Jun 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Dec 6, 2026
The maintenance fee for Therapeutically Active Compounds and Their Methods of Use (US 11,667,673) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
1 fee due Feb 8, 2027
The maintenance fee for Methods of use for trisubstituted benzotriazole derivatives (US 11,717,512) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
2 fees due Apr 8 to 22, 2027 · next Apr 8
2 fees due Jun 19 to 26, 2027 · next Jun 19
1 fee due Jul 9, 2027
The maintenance fee for Therapeutically active compounds and their methods of use (US 11,865,079) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
1 fee due Oct 7, 2027
The maintenance fee for Methods and compositions for cell-proliferation-related disorders (US 10,610,125) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
1 fee due Nov 5, 2027
The maintenance fee for Therapeutically Active Compositions and Their Methods of Use (US 10,640,534) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

2 of the patents on this record were granted since Aug 17, 2026
1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,610,125	Methods and compositions for cell-proliferation-related disorders In force Term ends Jun 21, 2030 · From the USPTO record	In force	Term ends Jun 21, 2030	From the USPTO record
US 8,883,438	Method for Diagnosing Cell Proliferation Disorders Having a Neoactive Mutation at Residue 97 of Isocitrate Dehydrogenase 1 In force Term ends Oct 21, 2030 · Medium confidence	In force	Term ends Oct 21, 2030	Medium confidence
US 9,982,309	Method for Treating Cell Proliferation Related Disorders In force Term ends Oct 21, 2030 · Medium confidence	In force	Term ends Oct 21, 2030	Medium confidence
US 10,711,314	Methods for Diagnosing Idh-Mutant Cell Proliferation Disorders In force Term ends Oct 21, 2030 · Medium confidence	In force	Term ends Oct 21, 2030	Medium confidence
US 9,434,979	Methods and compositions for cell-proliferation-related disorders In force Term ends Mar 2, 2031 · From the USPTO record	In force	Term ends Mar 2, 2031	From the USPTO record
US 9,512,107	Therapeutically Active Compositions and Their Methods of Use In force Term ends Jan 7, 2033 · High confidence	In force	Term ends Jan 7, 2033	High confidence
US 9,656,999	Therapeutically Active Compounds and Their Methods of Use In force Term ends Jan 7, 2033 · High confidence	In force	Term ends Jan 7, 2033	High confidence
US 10,294,215	Therapeutically Active Compounds and Their Methods of Use In force Term ends Jan 7, 2033 · Low confidence	In force	Term ends Jan 7, 2033	Low confidence
US 9,850,277	Therapeutically Active Compositions and Their Methods of Use In force Term ends Jan 18, 2033 · High confidence	In force	Term ends Jan 18, 2033	High confidence
US 10,640,534	Therapeutically Active Compositions and Their Methods of Use In force Term ends Jan 18, 2033 · High confidence	In force	Term ends Jan 18, 2033	High confidence

10 of 70 patents shown.

Pro members see all 70.

Pro members: see all 70 patents

Also on record, not counted in the 70: 3 patents in force now held by others · 14 lapsed for an unpaid fee · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 3 abandoned · 9 no status recorded

List them